Cyrus Biotechnology Scientist Erik Procko and the company’s lead ACE2-Fc Fusion protein COVID-19 therapeutic are featured in Science news article highlighting the exciting potential of decoy receptor drugs in fighting SARS-CoV-2, and other viral infections – (Science.com)
https://cyrusbio.com/wp-content/uploads/CyrusLogoStaggeredWhite.svg00Thomas Tuonghttps://cyrusbio.com/wp-content/uploads/CyrusLogoStaggeredWhite.svgThomas Tuong2023-02-06 09:18:382023-02-06 09:20:37Cyrus Biotechnology Scientist Erik Procko and the company’s lead ACE2-Fc Fusion protein COVID-19 therapeutic are featured in Science news article highlighting the exciting potential of decoy receptor drugs in fighting SARS-CoV-2, and other viral infections – (Science.com)